Sterile injectable drugs include products formulated using either chemical or biologically active pharmaceutical ingredients (APIs) for injection into a vein (intravenous, IV), muscle (intramuscular, IM), the space around the spinal cord (intrathecal), beneath the skin (subcutaneous, SC), or in the eye (intravitreal). Parenteral administration is the second most common method of drug delivery behind oral dosing, and injectable drug products, including vaccines, have been developed to treat and prevent many different types of diseases.
Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.
There is a wide array of sterile formats. All of the decisions regarding final formulation and packaging are driven by the route of injection. In this report, we cover sterile drug products that are intended for the following:[3]
Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.
Glass vials
Glassmaking has been around since at least 3500 BCE, although regular production of blown glass vials didn’t become prevalent until about 100 BCE in the Roman Empire. The ancient Egyptians, Assyrians, Romans, and many cultures in between used glass vials for essentially the same purpose we do today — it creates a durable, nonreactive vessel that can be sealed.
Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.